CSNK1D inhibition suppresses head and neck squamous cell carcinoma progression through SHH and PTCH1 pathway

Li Yang1,2, Xiang Li3, Yun Zhu1,4

  • 1Department of Oral and Maxillofacial Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.

Cell Death & Disease
|December 6, 2025
PubMed

Insights

Casein kinase 1 delta (CSNK1D) drives head and neck cancer progression by activating the hedgehog pathway. Inhibiting CSNK1D presents a potential new treatment strategy for HNSCC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Casein kinase 1 delta (CSNK1D) is implicated in cancer, but its role in head and neck squamous cell carcinoma (HNSCC) is not well understood.
  • Understanding CSNK1D's function is crucial for developing targeted therapies for HNSCC.

Purpose of the Study:

  • To investigate the biological functions and clinical significance of CSNK1D in HNSCC progression.
  • To elucidate the molecular mechanisms by which CSNK1D regulates HNSCC growth.
  • To evaluate CSNK1D as a potential therapeutic target for HNSCC.

Main Methods:

  • Analysis of CSNK1D expression in HNSCC tumor tissues.
  • Investigation of CSNK1D's interaction with SHH and PTCH1.
  • Assessment of the effect of CSNK1D on the GLI1-BCL2 axis and hedgehog pathway activation.
  • Evaluation of the inhibitory effect of SB-203580 on CSNK1D in HNSCC.

Main Results:

  • CSNK1D expression is upregulated in HNSCC tissues and correlates with poor patient survival.
  • CSNK1D interacts with SHH and PTCH1, stabilizing the complex and activating the GLI1-BCL2 axis.
  • Activation of the hedgehog pathway is mediated by CSNK1D in HNSCC.
  • SB-203580 effectively inhibits CSNK1D activity.

Conclusions:

  • CSNK1D is a critical oncogenic driver in HNSCC progression.
  • CSNK1D regulates HNSCC via the hedgehog pathway.
  • Targeting CSNK1D with inhibitors like SB-203580 offers a promising therapeutic strategy for HNSCC.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.4K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
9.7K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
511
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K